• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

滤泡性甲状腺癌:组织学和分期系统在预测生存中的作用。

Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.

作者信息

Lo Chung-Yau, Chan Wai-Fan, Lam King-Yin, Wan Koon-Yat

机构信息

Departments of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Pokfulam, Hong Kong, China.

出版信息

Ann Surg. 2005 Nov;242(5):708-15. doi: 10.1097/01.sla.0000186421.30982.d2.

DOI:10.1097/01.sla.0000186421.30982.d2
PMID:16244545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1409851/
Abstract

OBJECTIVE

To evaluate the risk factors including tumor histomorphology for survival specific to follicular thyroid carcinoma (FTC) and to apply commonly employed staging systems in predicting survival for patients with FTC.

SUMMARY BACKGROUND DATA

FTC is usually analyzed collectively with papillary thyroid carcinoma (PTC) in risk group analysis. Risk factors and risk group analysis are important in the management of patients with FTC, although current published therapeutic guidelines call for total thyroidectomy followed by radioactive iodine (I) ablation for all FTC patients.

METHODS

Over a 40-year period, 156 patients surgically treated for FTC with an average follow-up of 14.4 years were retrospectively studied after histologic reclassification according to the type and degree of invasiveness of the tumor. Potential risk factors for survival were calculated using multivariate analysis, and the prognostic accuracy of AMES risk group stratification, UICC/AJCC pTNM staging, Degroot classification, and MACIS scoring schemes in predicting survival was compared.

RESULTS

Seventeen (11%) patients had distant metastases at presentation, and bilateral thyroid resection was performed for 131 (84%) patients. Seventeen (11%) patients died of recurrent or metastatic disease. The overall and cancer-specific survival (CSS) rates at 10 years were 79% and 88%, respectively. None of the patients with minimally invasive (n = 49) or angioinvasive (n = 23) carcinomas died compared with 17 of 84 patients with widely invasive carcinomas (P = 0.0007). Using the Cox proportional hazards model, old age, the presence of distant metastases, and incomplete tumor excision were independent prognostic factors for survival. For patients who underwent curative treatment, old age and widely invasive carcinoma were risk factors for poor survival. All staging systems studied accurately predicted CSS, and the pTNM UICC/AJCC staging system yielded the best prognostic information.

CONCLUSIONS

Commonly adopted staging systems can be applied specifically to patients with FTC. The distinction of FTC in minimally invasive and widely invasive carcinoma based on the extent of invasiveness rather than vascular invasion is important in identifying low-risk FTC patients for a more conservative management.

摘要

目的

评估包括肿瘤组织形态学在内的影响滤泡状甲状腺癌(FTC)特异性生存的危险因素,并应用常用的分期系统预测FTC患者的生存情况。

总结背景数据

在风险组分析中,FTC通常与乳头状甲状腺癌(PTC)一起进行分析。尽管目前已发表的治疗指南要求对所有FTC患者进行全甲状腺切除,随后进行放射性碘(I)消融,但危险因素和风险组分析在FTC患者的管理中仍很重要。

方法

在40年的时间里,对156例接受手术治疗的FTC患者进行回顾性研究,平均随访14.4年,术后根据肿瘤的侵袭类型和程度进行组织学重新分类。使用多变量分析计算生存的潜在危险因素,并比较AMES风险组分层、UICC/AJCC pTNM分期、德格鲁特分类和MACIS评分方案在预测生存方面的预后准确性。

结果

17例(11%)患者初诊时已有远处转移,131例(84%)患者接受了双侧甲状腺切除术。17例(11%)患者死于复发或转移性疾病。10年时的总生存率和癌症特异性生存率(CSS)分别为79%和88%。与84例广泛侵袭性癌患者中的17例相比,49例微侵袭性癌患者和23例血管侵袭性癌患者均无死亡(P = 0.0007)。使用Cox比例风险模型,高龄、远处转移的存在和肿瘤切除不完全是生存的独立预后因素。对于接受根治性治疗的患者,高龄和广泛侵袭性癌是生存不良的危险因素。所研究的所有分期系统均能准确预测CSS,pTNM UICC/AJCC分期系统提供了最佳的预后信息。

结论

常用的分期系统可专门应用于FTC患者。根据侵袭范围而非血管侵袭区分微侵袭性和广泛侵袭性FTC对于识别低风险FTC患者以进行更保守的管理很重要。

相似文献

1
Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.滤泡性甲状腺癌:组织学和分期系统在预测生存中的作用。
Ann Surg. 2005 Nov;242(5):708-15. doi: 10.1097/01.sla.0000186421.30982.d2.
2
Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma.血管侵犯与微小浸润性滤泡状甲状腺癌患者死亡率增加相关,但与广泛浸润性滤泡状甲状腺癌无关。
Head Neck. 2014 Dec;36(12):1695-700. doi: 10.1002/hed.23511. Epub 2014 Feb 27.
3
Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.高分化甲状腺癌侵犯气道消化道:诊断、管理、预后及生物学特性
Laryngoscope. 2006 Jan;116(1):1-11. doi: 10.1097/01.MLG.0000200428.26975.86.
4
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.同质管理的pT3分化型甲状腺癌人群中的复发风险。
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
5
Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.碘充足的地方性甲状腺肿地区的滤泡性甲状腺癌:一项前瞻性收集、回顾性分析的临床试验。
Ann Surg. 2009 Jun;249(6):1023-31. doi: 10.1097/SLA.0b013e3181a77b7b.
6
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.乳头状和滤泡状甲状腺癌的病理肿瘤-淋巴结-转移(pTNM)分期:700例患者的回顾性分析
J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62. doi: 10.1210/jcem.82.11.4373.
7
Optimizing the treatment of AMES high-risk papillary thyroid carcinoma.优化AMES高危乳头状甲状腺癌的治疗
World J Surg. 2004 Nov;28(11):1103-9. doi: 10.1007/s00268-004-7420-6.
8
Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.比较第八版美国癌症联合委员会/肿瘤淋巴结转移分期系统在甲状腺乳头状癌和滤泡状癌中的预后价值。
Thyroid. 2018 Aug;28(8):976-981. doi: 10.1089/thy.2018.0066. Epub 2018 Jul 30.
9
Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.乳头状和滤泡状甲状腺癌的无病生存期。UICC第5版和第7版T分期分类的比较以及原发肿瘤大小的预后价值。
Nuklearmedizin. 2013;52(3):71-80. doi: 10.3413/Nukmed-0530-12-09. Epub 2013 Mar 13.
10
Follicular thyroid carcinoma: histology and prognosis.滤泡性甲状腺癌:组织学与预后
Cancer. 2004 Mar 15;100(6):1123-9. doi: 10.1002/cncr.20081.

引用本文的文献

1
[Update on follicular thyroid cancer-What is relevant for surgeons?].[滤泡性甲状腺癌的最新进展——对外科医生有何重要意义?]
Chirurgie (Heidelb). 2025 Mar 27. doi: 10.1007/s00104-025-02276-1.
2
Assessing the potential of high-mobility group AT-hook 2 immunohistochemical staining as a prognostic marker of metastatic recurrence in follicular thyroid cancer: a retrospective cohort study.评估高迁移率族AT钩蛋白2免疫组化染色作为滤泡性甲状腺癌转移复发预后标志物的潜力:一项回顾性队列研究。
Endocr J. 2025 May 7;72(5):535-543. doi: 10.1507/endocrj.EJ24-0557. Epub 2025 Feb 19.
3
Prognostic Factors for Cancer-Specific Survival and Disease-Free Interval in 130 Patients with Follicular Thyroid Carcinoma: Single Institution Experience.130例滤泡性甲状腺癌患者的癌症特异性生存和无病生存期的预后因素:单机构经验
Diagnostics (Basel). 2024 Dec 14;14(24):2817. doi: 10.3390/diagnostics14242817.
4
Management of follicular thyroid carcinoma.滤泡性甲状腺癌的治疗管理。
Eur Thyroid J. 2024 Oct 16;13(5). doi: 10.1530/ETJ-24-0146. Print 2024 Oct 1.
5
Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification.2022年世界卫生组织分类对嗜酸细胞性和滤泡性甲状腺癌重新分类的影响。
J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1343-e1350. doi: 10.1210/clinem/dgae581.
6
Risk factors for death of follicular thyroid carcinoma: a systematic review and meta-analysis.滤泡性甲状腺癌死亡的危险因素:系统评价和荟萃分析。
Endocrine. 2023 Dec;82(3):457-466. doi: 10.1007/s12020-023-03466-9. Epub 2023 Oct 7.
7
A nomogram for predicting overall survival in patients with follicular thyroid cancer after thyroidectomy: a SEER database analysis.甲状腺切除术后滤泡状甲状腺癌患者总生存预测列线图:一项监测、流行病学和最终结果(SEER)数据库分析
Gland Surg. 2022 Aug;11(8):1356-1366. doi: 10.21037/gs-22-386.
8
Ultrasound-Guided Thermal Ablation of Bethesda IV Thyroid Nodules: A Pilot Study.超声引导下 Bethesda IV 级甲状腺结节热消融治疗:一项初步研究。
Front Endocrinol (Lausanne). 2021 Aug 24;12:674970. doi: 10.3389/fendo.2021.674970. eCollection 2021.
9
Follicular Thyroid Carcinoma in a Developing Country: A 10-Year Retrospective Study.发展中国家的滤泡性甲状腺癌:一项10年回顾性研究
Cureus. 2021 Jul 23;13(7):e16594. doi: 10.7759/cureus.16594. eCollection 2021 Jul.
10
Diagnostic Utility of Radiomics in Thyroid and Head and Neck Cancers.影像组学在甲状腺癌和头颈部癌中的诊断效用
Front Oncol. 2021 Jul 7;11:639326. doi: 10.3389/fonc.2021.639326. eCollection 2021.

本文引用的文献

1
Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome.滤泡性甲状腺癌患者的预后评分系统:不同分期系统在预测患者预后方面的比较
Thyroid. 2004 Jun;14(6):453-8. doi: 10.1089/105072504323150778.
2
Follicular thyroid carcinoma: histology and prognosis.滤泡性甲状腺癌:组织学与预后
Cancer. 2004 Mar 15;100(6):1123-9. doi: 10.1002/cncr.20081.
3
Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.甲状腺乳头状癌和滤泡状癌中组织学血管侵犯的临床病理意义
J Am Coll Surg. 2004 Mar;198(3):341-8. doi: 10.1016/j.jamcollsurg.2003.11.012.
4
Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.分期系统在碘替代的地方性甲状腺肿地区分化型甲状腺癌中的应用。
Ann Surg. 2003 Feb;237(2):227-34. doi: 10.1097/01.SLA.0000048449.69472.81.
5
Minimally invasive follicular thyroid carcinoma: completion thyroidectomy or not?微创滤泡性甲状腺癌:是否行甲状腺全切术?
ANZ J Surg. 2002 Nov;72(11):844-5.
6
Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma.甲状腺内高分化滤泡状甲状腺癌患者的保守治疗
Surgery. 2001 Jul;130(1):30-5. doi: 10.1067/msy.2001.115364.
7
A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature.甲状腺微小浸润性滤泡癌的临床病理研究及英文文献复习
Cancer. 2001 Feb 1;91(3):505-24. doi: 10.1002/1097-0142(20010201)91:3<505::aid-cncr1029>3.0.co;2-6.
8
Papillary thyroid carcinoma: prognostic index for survival including the histological variety.甲状腺乳头状癌:包括组织学类型的生存预后指数。
Arch Surg. 2000 Mar;135(3):272-7. doi: 10.1001/archsurg.135.3.272.
9
Follicular carcinoma of the thyroid gland: prognostic factors, treatment, and survival.甲状腺滤泡状癌:预后因素、治疗及生存情况
Am J Clin Oncol. 2000 Feb;23(1):1-5. doi: 10.1097/00000421-200002000-00001.
10
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.手术、放射性碘及外照射放疗对分化型甲状腺癌患者临床结局的影响。
Cancer. 1998 Jan 15;82(2):375-88.